• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Bull World Health Organ . COVID-19 response: effectiveness of weekly rapid risk assessments, Italy

tetano

Editor, Senior Moderator
Bull World Health Organ


. 2022 Feb 1;100(2):161-167.
doi: 10.2471/BLT.21.286317. Epub 2021 Nov 25.
COVID-19 response: effectiveness of weekly rapid risk assessments, Italy


Flavia Riccardo[SUP] 1 [/SUP], Giorgio Guzzetta[SUP] 2 [/SUP], Alberto Mateo Urdiales[SUP] 1 [/SUP], Martina Del Manso[SUP] 1 [/SUP], Xanthi D Andrianou[SUP] 1 [/SUP], Antonino Bella[SUP] 1 [/SUP], Patrizio Pezzotti[SUP] 1 [/SUP], Simona Carbone[SUP] 3 [/SUP], Tiziana De Vito[SUP] 3 [/SUP], Francesco Maraglino[SUP] 3 [/SUP], Vittorio Demicheli[SUP] 4 [/SUP], Claudio Dario[SUP] 5 [/SUP], Enrico Coscioni[SUP] 6 [/SUP], Giovanni Rezza[SUP] 3 [/SUP], Andrea Urbani[SUP] 3 [/SUP], Stefano Merler[SUP] 2 [/SUP], Silvio Brusaferro[SUP] 1 [/SUP], Italian COVID-19 monitoring group



Affiliations

Abstract

in English, French, Spanish, Arabic, Chinese, Russian
Problem: After Italy's first national restriction measures in 2020, a robust approach was needed to monitor the emerging epidemic of coronavirus disease 2019 (COVID-19) at subnational level and provide data to inform the strengthening or easing of epidemic control measures.
Approach: We adapted the European Centre for Disease Prevention and Control rapid risk assessment tool by including quantitative and qualitative indicators from existing national surveillance systems. We defined COVID-19 risk as a combination of the probability of uncontrolled transmission of severe acute respiratory syndrome coronavirus 2 and of an unsustainable impact of COVID-19 cases on hospital services, adjusted in relation to the health system's resilience. The monitoring system was implemented with no additional cost in May 2020.
Local setting: The infectious diseases surveillance system in Italy uses consistent data collection methods across the country's decentralized regions and autonomous provinces.
Relevant changes: Weekly risk assessments using this approach were sustainable in monitoring the epidemic at regional level from 4 May 2020 to 24 September 2021. The tool provided reliable assessments of when and where a rapid increase in demand for health-care services would occur if control or mitigation measures were not increased in the following 3 weeks.
Lessons learnt: Although the system worked well, framing the risk assessment tool in a legal decree hampered its flexibility, as indicators could not be changed without changing the law. The relative complexity of the tool, the impossibility of real-time validation and its use for the definition of restrictions posed communication challenges.
 
Back
Top Bottom